<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.27322.025</object-id><label>Table 2.</label><caption><p>Structural mapping of disease-associated mutations in GIPCs.&#160;Listed mutations are based on (<xref ref-type="bibr" rid="bib3">Ammar-Khodja et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Katoh, 2013</xref>). HNSCC, head and neck squamous cell carcinoma. Mutations are mapped to GIPC1 based on the sequence alignment of GIPC1, 2 and 3 as shown in <xref ref-type="fig" rid="fig1s2">Figure 1&#8212;figure supplement 2</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.27322.025">http://dx.doi.org/10.7554/eLife.27322.025</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"><bold>Gene</bold></th><th valign="top"><bold>Mutation</bold></th><th valign="top"><bold>Disease</bold></th><th valign="top"><bold>Corresponding residue in GIPC1</bold></th><th valign="top"><bold>Location and function of</bold> <break/><bold>the mutated residue</bold></th><th valign="top"><bold>Possible effect of the mutation</bold></th></tr></thead><tbody><tr><td valign="top">GIPC1</td><td valign="top">F319L</td><td valign="top">HNSCC</td><td valign="top">F319</td><td valign="top">GH2, <break/>Interface II for myosin VI</td><td valign="top">Weaken binding to myosin VI</td></tr><tr><td valign="top">GIPC2</td><td valign="top">F74Y</td><td valign="top">Colorectal cancer</td><td valign="top">F90</td><td valign="top">GH1, <break/>Hydrophobic core</td><td valign="top">Destabilize the structure</td></tr><tr><td valign="top">GIPC2</td><td valign="top">G102E</td><td valign="top">Ovarian cancer</td><td valign="top">G118</td><td valign="top">GH1, <break/>Domain-swapped dimer Interface</td><td valign="top">Destabilize the structure</td></tr><tr><td valign="top">GIPC3</td><td valign="top">M88I</td><td valign="top">Familial hearing loss</td><td valign="top">M109</td><td valign="top">GH1, <break/>Inter-domain interface with PDZ</td><td valign="top">Destabilize the structure</td></tr><tr><td valign="top">GIPC3</td><td valign="top">G94D</td><td valign="top">Familial hearing loss</td><td valign="top">G115</td><td valign="top">GH1, autoinhibitory interface with GH2, <break/>Part of the hydrophobic pocket accommodating the I1918/Y1919 motif in PlexinD1</td><td valign="top">Disrupt the autoinhibited state, <break/>Weaken cargo binding</td></tr><tr><td valign="top">GIPC3</td><td valign="top">H170N</td><td valign="top">Familial hearing loss</td><td valign="top">H191</td><td valign="top">PDZ, <break/>Key PBM binding residue</td><td valign="top">Weaken cargo binding</td></tr><tr><td valign="top">GIPC3</td><td valign="top">T221I</td><td valign="top">Familial hearing loss</td><td valign="top">T242</td><td valign="top">PDZ/GH2 Linker, <break/>Autoinhibitory interface with GH2</td><td valign="top">Alter the autoinhibited state</td></tr><tr><td valign="top">GIPC3</td><td valign="top">M255K</td><td valign="top">Familial hearing loss</td><td valign="top">M276</td><td valign="top">GH2, <break/>Autoinhibitory interface with PDZ, <break/>Interface I for myosin VI</td><td valign="top">Alter the autoinhibited state, weaken binding to myosin VI</td></tr><tr><td valign="top">GIPC3</td><td valign="top">G256D</td><td valign="top">Familial hearing loss</td><td valign="top">G277</td><td valign="top">GH2, <break/>Autoinhibitory interface with PDZ <break/>Interface I for myosin VI</td><td valign="top">Alter the autoinhibited state, weaken binding to myosin VI</td></tr><tr><td valign="top">GIPC3</td><td valign="top">L262R</td><td valign="top">Familial hearing loss</td><td valign="top">L283</td><td valign="top">GH2, <break/>Autoinhibitory interface with PDZ, <break/>Interface I for myosin VI</td><td valign="top">Alter the autoinhibited state, weaken binding to myosin VI</td></tr></tbody></table></table-wrap>